| Mrs Debra Lynn Prox, OTR | |
|
2130 Continental Dr, West Bend, WI 53095-7904 | |
| (262) 338-0092 | |
| Not Available |
| Full Name | Mrs Debra Lynn Prox |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 29 Years |
| Location | 2130 Continental Dr, West Bend, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376054403 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 2562-26 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fox Rehabilitation Services Wi Llc | 1658647581 | 106 |
News Archive
The president and Congress are delving into issues of age rating, which most acutely affects people in their fifties and early sixties before they qualify for Medicare.
A research work carried out at the Laboratory of Forensic Anthropology of the University of Granada will speed up the identification of more than 2,000 missing persons in Kosovo during former Yugoslavia war, besides developing a new forensic technique based on the study of ribs and pubis, which will be very useful for the identification of persons in armed conflicts. This work, pioneer all over the world, has involved the study of one of the greatest forensic samples never before analysed.
Aerovance Inc. announced that it has received clearance from the U.S. Food and Drug Administration (FDA) and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate Aerovance's Phase IIb clinical trial, AeroTrial, of inhaled dry powder Aerovant in patients with uncontrolled asthma.
Myriad Genetics, Inc. today announced results from PROCEDE 500, a clinical utility study with its Prolaris test, at the 2014 ASCO Genitourinary Cancers Symposium in San Francisco, Calif. The study demonstrated the significant clinical value of Prolaris to physicians who are treating men with prostate cancer. Prolaris is a prognostic test that accurately predicts prostate cancer-specific death and metastases and has been validated in 11 clinical studies with more than 5,000 patients.
Dell has received CEO Cancer Gold Standard™ accreditation, recognizing the company's commitment to reducing the cancer risk of its employees and their families by encouraging healthy lifestyles and promoting early detection through screenings, and by providing quality care, including access to cancer clinical trials, when a cancer diagnosis becomes a reality.
› Verified 3 days ago
| Provider Name | Fox Rehabilitation Services Wi Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1518483973 PECOS PAC ID: 1658647581 Enrollment ID: O20171020002309 |
News Archive
The president and Congress are delving into issues of age rating, which most acutely affects people in their fifties and early sixties before they qualify for Medicare.
A research work carried out at the Laboratory of Forensic Anthropology of the University of Granada will speed up the identification of more than 2,000 missing persons in Kosovo during former Yugoslavia war, besides developing a new forensic technique based on the study of ribs and pubis, which will be very useful for the identification of persons in armed conflicts. This work, pioneer all over the world, has involved the study of one of the greatest forensic samples never before analysed.
Aerovance Inc. announced that it has received clearance from the U.S. Food and Drug Administration (FDA) and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate Aerovance's Phase IIb clinical trial, AeroTrial, of inhaled dry powder Aerovant in patients with uncontrolled asthma.
Myriad Genetics, Inc. today announced results from PROCEDE 500, a clinical utility study with its Prolaris test, at the 2014 ASCO Genitourinary Cancers Symposium in San Francisco, Calif. The study demonstrated the significant clinical value of Prolaris to physicians who are treating men with prostate cancer. Prolaris is a prognostic test that accurately predicts prostate cancer-specific death and metastases and has been validated in 11 clinical studies with more than 5,000 patients.
Dell has received CEO Cancer Gold Standard™ accreditation, recognizing the company's commitment to reducing the cancer risk of its employees and their families by encouraging healthy lifestyles and promoting early detection through screenings, and by providing quality care, including access to cancer clinical trials, when a cancer diagnosis becomes a reality.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Debra Lynn Prox, OTR W300n8731 County Rd E, Hartland, WI 53029-9512 Ph: (262) 966-2071 | Mrs Debra Lynn Prox, OTR 2130 Continental Dr, West Bend, WI 53095-7904 Ph: (262) 338-0092 |
News Archive
The president and Congress are delving into issues of age rating, which most acutely affects people in their fifties and early sixties before they qualify for Medicare.
A research work carried out at the Laboratory of Forensic Anthropology of the University of Granada will speed up the identification of more than 2,000 missing persons in Kosovo during former Yugoslavia war, besides developing a new forensic technique based on the study of ribs and pubis, which will be very useful for the identification of persons in armed conflicts. This work, pioneer all over the world, has involved the study of one of the greatest forensic samples never before analysed.
Aerovance Inc. announced that it has received clearance from the U.S. Food and Drug Administration (FDA) and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate Aerovance's Phase IIb clinical trial, AeroTrial, of inhaled dry powder Aerovant in patients with uncontrolled asthma.
Myriad Genetics, Inc. today announced results from PROCEDE 500, a clinical utility study with its Prolaris test, at the 2014 ASCO Genitourinary Cancers Symposium in San Francisco, Calif. The study demonstrated the significant clinical value of Prolaris to physicians who are treating men with prostate cancer. Prolaris is a prognostic test that accurately predicts prostate cancer-specific death and metastases and has been validated in 11 clinical studies with more than 5,000 patients.
Dell has received CEO Cancer Gold Standard™ accreditation, recognizing the company's commitment to reducing the cancer risk of its employees and their families by encouraging healthy lifestyles and promoting early detection through screenings, and by providing quality care, including access to cancer clinical trials, when a cancer diagnosis becomes a reality.
› Verified 3 days ago
Mrs. Aimee Hodorowski, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 5595 County Road Z, West Bend, WI 53095 Phone: 262-306-2100 | |
Mary Ognenoff, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3200 Pleasant Valley Rd, West Bend, WI 53095 Phone: 262-677-6805 Fax: 262-677-6801 | |
Miranda Gazza, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 531 E Washington St, West Bend, WI 53095 Phone: 262-335-4500 | |
Ellie Jean Mcmeeken, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1700 W Paradise Dr, West Bend, WI 53095 Phone: 262-334-3451 | |
Regina Zehnder, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2130 Continental Dr, West Bend, WI 53095 Phone: 877-407-3422 Fax: 877-407-4329 | |
Lisa Lipski, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5595 County Road Z, West Bend, WI 53095 Phone: 262-306-2100 | |
Elizabeth Marie Bohn, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 620 Schoenhaar Dr, West Bend, WI 53090 Phone: 262-306-8450 |